SCHEMBL14008941

SCHEMBL14008941

Cc1cc(N2CCOCC2)ccc1NC(=O)c1ccc(C(=O)Nc2ccc(-n3cncn3)c(F)c2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ HTT P42858 2/20 0.46
▸ BLM P54132 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ BRAF P15056 1/20 0.42
▸ PDE7A Q13946 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ DGAT1 O75907 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ F10 P00742 1/20 0.40
▸ CHRNA1 P02708 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14008947 0.89 PDE7A (0.46) KMT2ANPC1RAB9AHTTMEN1
SCHEMBL14009024 0.87 BLM (0.43) KMT2ANPC1RAB9AHTTBLM
SCHEMBL14009306 0.85 RAB9A (0.54) KMT2ANPC1RAB9AHTTBLM
SCHEMBL14008963 0.82 CYP1A2 (0.47) KMT2ARAB9ABLMMEN1LMNA
SCHEMBL14009078 0.80 BLM (0.47) KMT2ARAB9ABLMKDM4EHSP90AA1
SCHEMBL14009026 0.80 RAB9A (0.46) NPC1RAB9AHTTBRAFPDE7A
SCHEMBL14009029 0.80 BLM (0.46) RAB9ABLMKDM4EHSP90AA1ATM
SCHEMBL14009000 0.80 BLM (0.43) BLMBRAFPDE7AHSP90AA1ATM
SCHEMBL14009032 0.79 MAPKAPK2 (0.46) RAB9ABRAFPDE7AHSP90AA1ATM
SCHEMBL14008962 0.78 BLM (0.46) NPC1RAB9ABLMHSP90AA1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 KMT2A 806/4885NPC1 4547/4885RAB9A 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback